Drug Shortage Report for HALOPERIDOL INJECTION

Last updated on 2022-06-23 History
Report ID 163328
Drug Identification Number 02366010
Brand name HALOPERIDOL INJECTION
Common or Proper name Haloperidol Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-07-11
Actual start date
Estimated end date 2022-08-01
Actual end date
Shortage status Anticipated shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-06-23 French Compare
v1 2022-06-23 English Compare

Showing 1 to 2 of 2